The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 15,304,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| ALIGOS THERAPEUTICS INC | COM | 01626L105 | 874,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| ALLAKOS INC | COM | 01671P100 | 24,638,164 | 5,536,666 | SH | SOLE | 5,536,666 | 0 | 0 | |||
| ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 6,780,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 52,768,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | |||
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 16,083,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | 13,897,968 | 1,044,960 | SH | SOLE | 1,044,960 | 0 | 0 | |||
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 15,952,500 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | |||
| BIOGEN INC | COM | 09062X103 | 27,803,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| BIOHAVEN LTD | COM | G1110E107 | 9,562,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | |||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 14,586,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 10,790,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 3,488,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 43,987,500 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | |||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 16,141,581 | 2,797,501 | SH | SOLE | 2,797,501 | 0 | 0 | |||
| DICE THERAPEUTICS INC | COM | 23345J104 | 11,746,500 | 410,000 | SH | SOLE | 410,000 | 0 | 0 | |||
| DISC MEDICINE INC | COM | 254604101 | 11,124,750 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | |||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 19,584,000 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 8,786,915 | 401,229 | SH | SOLE | 401,229 | 0 | 0 | |||
| FIBROGEN INC | COM | 31572Q808 | 5,598,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
| GALAPAGOS NV | SPON ADR | 36315X101 | 13,524,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
| GERON CORP | COM | 374163103 | 7,703,500 | 3,550,000 | SH | SOLE | 3,550,000 | 0 | 0 | |||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 49,428,000 | 3,600,000 | SH | SOLE | 3,600,000 | 0 | 0 | |||
| IMMUNIC INC | COM | 4525EP101 | 627,564 | 421,184 | SH | SOLE | 421,184 | 0 | 0 | |||
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 24,720,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
| IMMUNOVANT INC | COM | 45258J102 | 38,775,000 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | |||
| IVERIC BIO INC | COM | 46583P102 | 36,981,600 | 1,520,000 | SH | SOLE | 1,520,000 | 0 | 0 | |||
| KARUNA THERAPEUTICS INC | COM | 48576A100 | 18,164,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| LIANBIO | SPONSORED ADS | 53000N108 | 548,800 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | |||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 12,113,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
| MINERALYS THERAPEUTICS INC | COM | 603170101 | 4,698,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
| MORPHOSYS AG | SPONSORED ADS | 617760202 | 5,940,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 20,244,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 8,000 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | |||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 12,991,246 | 3,743,875 | SH | SOLE | 3,743,875 | 0 | 0 | |||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 15,417,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | |||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 30,322,600 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | |||
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 8,326,500 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
| TYRA BIOSCIENCES INC | COM | 90240B106 | 1,408,905 | 87,673 | SH | SOLE | 87,673 | 0 | 0 | |||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 9,045,000 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | |||
| VIGIL NEUROSCIENCE INC | COM | 92673K108 | 1,844,338 | 188,390 | SH | SOLE | 188,390 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 24,168,000 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | |||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 32,211,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | |||